NCT07629869 COPD Flare-Up Clinic After Severe Exacerbations
| NCT ID | NCT07629869 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Condition | COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2026-07-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized controlled trial evaluates whether a specialized "COPD flare-up clinic service" improves outcomes in patients following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Patients presenting to the emergency department with AECOPD and discharged or hospitalized will be randomized 1:1 to either structured follow-up in a dedicated flare-up clinic or standard follow-up by scheduled telephone interviews. The researches hypothesize that structured follow-up in a specialized clinic will reduce recurrent exacerbations, optimize long-term COPD management, and improve patients' quality of life compared to standard care.
Eligibility Criteria
Inclusion Criteria: * Prior COPD diagnosis based on clinical and spirometry accepted criteria. * Acute exacerbation of COPD as the main reason for ED arrival. * Ability to perform in-person and telephone follow-up. * Agree to participate, with a signed informed consent. Exclusion Criteria: * Symptomatic heart failure as the main reason for emergency department visit in the last 6 months. * Uncontrolled comorbidity. * Vulnerable Populations: To ensure ethical compliance and participant safety, the study will exclude vulnerable populations. This includes pregnant women, and any person lacking the mental or legal capacity to provide independent informed consent.
Frequently Asked Questions
Who can join the NCT07629869 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07629869 currently recruiting?
Yes, NCT07629869 is actively recruiting participants. Visit ClinicalTrials.gov or contact Tel-Aviv Sourasky Medical Center to inquire about joining.
Where is the NCT07629869 trial being conducted?
This trial is being conducted at Tel Aviv, Israel.
Who is sponsoring the NCT07629869 clinical trial?
NCT07629869 is sponsored by Tel-Aviv Sourasky Medical Center. The trial plans to enroll 240 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.